Delphinus Medical Technologies developed the SoftVue Breast Ultrasound Tomography (UST). SoftVue UST is an imaging modality designed specifically to find more cancer in women with dense breasts and is an ultrasound-based breast imaging system that is FDA-approved for same-day screening as mammography. Delphinus designed the system as an adjunct to mammography for women with dense breasts to address the fact that breast cancer screening with mammography alone reduces mortality by 41% in women with non-dense breasts but reduces mortality by only 13% in women with dense breasts.
